Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Short-term outcomes of a phase II trial of perioperative capecitabine plus oxaliplatin therapy for advanced gastric cancer with extensive lymph node metastases (OGSG1701).
Kimura Y, Sugimoto N, Endo S, Kawabata R, Matsuyama J, Takeno A, Nakamura M, Takeshita H, Satake H, Tamura S, Sakai D, Kawakami H, Kurokawa Y, Shimokawa T, Satoh T. Kimura Y, et al. Among authors: matsuyama j. Gastric Cancer. 2025 Jan;28(1):112-121. doi: 10.1007/s10120-024-01564-9. Epub 2024 Nov 9. Gastric Cancer. 2025. PMID: 39520591 Clinical Trial.
Which is a more appropriate recipient for posterior circulation bypass surgery: V3 or V2? Differences in underlying disease and lesion sites between extracranial vertebral artery dissection and atherosclerotic changes. Illustrative cases.
Nishimura S, Saito M, Okuyama S, Kubota K, Matsuyama J, Takemura A, Matsushima T, Watanabe K. Nishimura S, et al. Among authors: matsuyama j. J Neurosurg Case Lessons. 2024 Jun 17;7(25):CASE24113. doi: 10.3171/CASE24113. Print 2024 Jun 17. J Neurosurg Case Lessons. 2024. PMID: 38885534 Free PMC article.
Efficacy and survival of nivolumab treatment for recurrent/unresectable esophageal squamous-cell carcinoma: real-world clinical data from a large multi-institutional cohort.
Makino T, Nakai S, Momose K, Yamashita K, Tanaka K, Miyata H, Yamamoto S, Motoori M, Kimura Y, Ushimaru Y, Hirao M, Matsuyama J, Akamaru Y, Kurokawa Y, Eguchi H, Doki Y. Makino T, et al. Among authors: matsuyama j. Esophagus. 2024 Jul;21(3):319-327. doi: 10.1007/s10388-024-01056-w. Epub 2024 May 8. Esophagus. 2024. PMID: 38717686 Free PMC article.
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).
Sunakawa Y, Sakamoto Y, Kawabata R, Ishiguro A, Akamaru Y, Kito Y, Takahashi M, Matsuyama J, Yabusaki H, Makiyama A, Suzuki T, Tsuda M, Yasui H, Hihara J, Takeno A, Inoue E, Ichikawa W, Fujii M. Sunakawa Y, et al. Among authors: matsuyama j. Oncologist. 2024 Aug 5;29(8):e997-e1002. doi: 10.1093/oncolo/oyae056. Oncologist. 2024. PMID: 38581687 Free PMC article.
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.
Saito T, Kurokawa Y, Fujitani K, Kawabata R, Takeno A, Mikami J, Endo S, Matsuyama J, Akamaru Y, Hirota M, Kishi K, Urakawa S, Yamamoto K, Tanaka K, Takahashi T, Oka M, Wada H, Eguchi H, Doki Y. Saito T, et al. Among authors: matsuyama j. Br J Cancer. 2024 Apr;130(7):1157-1165. doi: 10.1038/s41416-023-02540-3. Epub 2024 Feb 7. Br J Cancer. 2024. PMID: 38326601 Free PMC article.
Effects of postoperative oral elemental nutritional supplement on skeletal muscle loss after gastrectomy for gastric cancer.
Nishikawa K, Kimura Y, Kishi K, Inoue K, Matsuyama J, Akamaru Y, Tamura S, Kawada J, Kawase T, Kawabata R, Fujiwara Y, Kanno H, Yamada T, Shimokawa T, Imamura H. Nishikawa K, et al. Among authors: matsuyama j. Int J Clin Oncol. 2024 Mar;29(3):266-275. doi: 10.1007/s10147-023-02462-3. Epub 2024 Jan 16. Int J Clin Oncol. 2024. PMID: 38227091
Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902).
Kawase T, Imamura H, Kawabata R, Matsuyama J, Nishikawa K, Yanagihara K, Yamamoto K, Hoki N, Kawada J, Kawakami H, Sakai D, Kurokawa Y, Shimokawa T, Satoh T. Kawase T, et al. Among authors: matsuyama j. Int J Clin Oncol. 2024 Feb;29(2):134-141. doi: 10.1007/s10147-023-02437-4. Epub 2024 Jan 16. Int J Clin Oncol. 2024. PMID: 38227090 Clinical Trial.
192 results